KRRO Latest Press Releases

-- August 14, 2026 --

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- August 6, 2026 --

Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- July 10, 2026 --

Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- May 27, 2026 --

Korro to Present at the 2026 Jefferies Global Healthcare Conference Globe Newswire 7:00 AM

-- May 19, 2026 --

Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD) Globe Newswire 7:00 AM

-- May 15, 2026 --

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- May 7, 2026 --

Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- May 5, 2026 --

Korro to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- April 16, 2026 --

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences Globe Newswire 7:30 AM

-- April 10, 2026 --

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software